Drug intelligence / Profile preview

mupirocin

Development stage
Approved
Lead developer
GSK
Modality
Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Topical, Intranasal
01

Overview

Mupirocin is a naturally occurring topical antibiotic derived from *Pseudomonas fluorescens*, primarily used to treat superficial skin infections such as impetigo, folliculitis, and secondary traumatic skin lesions caused by susceptible bacteria including *Staphylococcus aureus* (including MRSA) and *Streptococcus pyogenes*. It is also used intranasally for the eradication of nasal carriage of MRSA. Mupirocin acts by reversibly inhibiting bacterial isoleucyl-tRNA synthetase, leading to inhibition of protein synthesis and ultimately bacteriostasis or bactericidal effects at higher concentrations. It does not exhibit cross-resistance with other classes of antibiotics due to its unique mechanism. Mupirocin is available only in topical formulations because it undergoes rapid systemic metabolism. Common side effects include local irritation such as burning, stinging, or itching at the application site[1][2][3][4][5].

Brand names
BactrobanCentany
Other names
pseudomonic acid Amupirocinemupirocin calciumpseudomonic acid
02

Targets

IleRS (Isoleucyl-tRNA synthetase)

Beyond the preview

Go deeper on mupirocin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mupirocin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call